Skip to main content

Nutritional Therapy in the Management of Physical Frailty and Sarcopenia

  • Chapter
  • First Online:
Frailty and Sarcopenia in Cirrhosis

Abstract

Sarcopenia and frailty are frequent in liver cirrhosis and are associated with a worse prognosis. For this reason, and being potentially modifiable disorders, to find a strategy to prevent or improve these conditions is of great importance in cirrhotic patients.

To date, there are no standardized treatments to reverse or prevent the deterioration of nutritional status and physical frailty in patients with liver cirrhosis. However, nutritional intervention and individual counseling to achieve adequate amounts of calories and proteins are recommended. Oral nutritional supplementations with BCAA or leucine or beta-hydroxy-beta-methyl butyrate combined with exercise training are promising measures, but more studies are needed to define the best way and time to operate with these approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lai JC, Covinsky KE, Dodge JL, Boscardin WJ, Segev DL, Roberts JP, Feng S. Development of a novel frailty index to predict mortality in patients with end-stage liver disease. Hepatology. 2017;66(2):564–74.

    Article  PubMed  Google Scholar 

  2. Montano-Loza AJ, Meza-Junco J, Prado CM, Lieffers JR, Baracos VE, Bain VG, et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2012;10:166–173 e161.

    Article  PubMed  Google Scholar 

  3. Merli M, Riggio O, Dally L. Does malnutrition affect survival in cirrhosis? PINC (Policentrica Italiana Nutrizione Cirrosi). Hepatology. 1996;23:1041–6.

    Article  CAS  PubMed  Google Scholar 

  4. van Vugt JLA, Alferink LJM, Buettner S, Gaspersz MP, Bot D, Murad SD, et al. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates. J Hepatol. 2017;68:707–14.

    Article  PubMed  Google Scholar 

  5. McClave SA, Di Baise JK, Mullin GE, Martindale RG. ACG Clinical Guideline: Nutrition therapy in the adult hospitalized patient. Am J Gastroenterol. 2016.

    Google Scholar 

  6. Tarazona-Santabalbina FJ, Gómez-Cabrera MC, Pérez-Ros P, Martínez-Arnau FM, Cabo H, Tsaparas K, Salvador-Pascual A, Rodriguez-Mañas L, Viña J. A multicomponent exercise intervention that reverses frailty and improves cognition, emotion, and social networking in the community-dwelling frail elderly: a randomized clinical trial. J Am Med Dir Assoc. 2016;17:426–33.

    Article  PubMed  Google Scholar 

  7. Ng TP, Feng L, Nyunt MS, Feng L, Niti M, Tan BY, Chan G, Khoo SA, Chan SM, Yap P, Yap KB. Nutritional, physical, cognitive, and combination interventions and frailty reversal among older adults: a randomized controlled trial. Am J Med. 2015;128:1225–1236.e1.

    Article  PubMed  Google Scholar 

  8. Kok B, Tandon P. Frailty in patients with cirrhosis. Curr Treat Options Gastroenterol. 2018;16:215–25.

    Article  PubMed  Google Scholar 

  9. Lattanzi B, D’Ambrosio D, Fedele F, Merli M. Nutritional assessment and management for hospitalized patients with cirrhosis. Current Hepatology Reports. 2018; https://doi.org/10.1007/s11901-018-0398-6.

  10. Laube R, Wang H, Park L, Heyman JK, Vidot H, Majumdar A, Strasser SI, McCaughan GW, Liu K. Frailty in advanced liver disease. Liver Int. 2018;38:2117–28.

    Article  PubMed  Google Scholar 

  11. Smith-Ray RL, Hughes SL, Prohaska TR, Little DM, Jurivich DA, Hedeker D. Impact of cognitive training on balance and gait in older adults. J Gerontol B Psychol Sci Soc Sci. 2015;70(3):357–66.

    Article  PubMed  Google Scholar 

  12. Li KZ, Roudaia E, Lussier M, Bherer L, Leroux A, McKinley PA. Benefits of cognitive dual task training on balance performance in healthy older adults. J Gerontol A Biol Sci Med Sci. 2010;65(12):1344–52.

    Article  PubMed  Google Scholar 

  13. Theou O, Stathokostas L, Roland K, et al. The effectiveness of exercise interventions for the management of frailty: a systematic review. J Aging Res. 2011;2011:569194.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Willis SL, Tennstedt SL, Marsiske M, et al. Long-term effects of cognitive training on everyday functional outcomes in older adults. JAMA. 2006;296(23):2805–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Doumas M, Rapp MA, Krampe RT. Working memory and postural control: adult age differences in potential for improvement, task priority, and dual tasking. J Gerontol B Psychol Sci Soc Sci. 2009;64(2):193–201.

    Article  PubMed  Google Scholar 

  16. Kim CO, Lee KR. Preventive effect of protein-energy supplementation on the functional decline of frail older adults with low socioeconomic status: a community-based randomized controlled study. J Gerontol A Biol Sci Med Sci. 2013;68(3):309–16.

    Article  CAS  PubMed  Google Scholar 

  17. Rosendahl E, Lindelöf N, Littbrand H, et al. High-intensity functional exercise program and protein-enriched energy supplement for older persons dependent in activities of daily living: a randomised controlled trial. Aust J Physiother. 2006;52(2):105–13.

    Article  PubMed  Google Scholar 

  18. Milne AC, Avenell A, Potter J. Meta-analysis: protein and energy supplementation in older people. Ann Intern Med. 2006;144(1):37–48.

    Article  CAS  PubMed  Google Scholar 

  19. Payette H, Boutier V, Coulombe C, Gray-Donald K. Benefits of nutritional supplementation in free-living, frail, undernourished elderly people: a prospective randomized community trial. J Am Diet Assoc. 2002;102(8):1088–95.

    Article  PubMed  Google Scholar 

  20. Fiatarone MA, O’Neill EF, Ryan ND, et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med. 1994;330(25):1769–75.

    Article  CAS  PubMed  Google Scholar 

  21. Park Y, Choi JE, Hwang HS. Protein supplementation improves muscle mass and physical performance in undernourished prefrail and frail elderly subjects: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2018;108:1026–33.

    Article  PubMed  Google Scholar 

  22. Calvani R, Miccheli A, Landi F, Bossola M, Cesari M, Leeuwenburgh C, Sieber CC, Bernabei R, Marzetti E. Current nutritional recommendations and novel dietary strategies to manage sarcopenia. J Frailty Aging. 2013;2:38–53.

    PubMed  PubMed Central  Google Scholar 

  23. Malafarina V, Uriz-Otano F, Iniesta R, Gil-Guerrero L. Effectiveness of nutritional supplementation on muscle mass in the treatment of sarcopenia in old age: a systematic review. J Am Med Dir Assoc. 2013;14(1):10–7.

    Article  PubMed  Google Scholar 

  24. Marzetti E, Cesari M, Calvani R, Msihid J, Tosato M, Rodriguez-Mañas L, Lattanzio F, Cherubini A, Bejuit R, Di Bari M, Maggio M, Vellas B, Dantoine T, Cruz-Jentoft AJ, Sieber CC, Freiberger E, Skalska A, Grodzicki T, Sinclair AJ, Topinkova E, Rýznarová I, Strandberg T, AMWJ S, JMGA S, Roller-Wirnsberger R, Jónsson PV, Ramel A, Del Signore S, Pahor M, Roubenoff R, Bernabei R, Landi F. SPRINTT Consortium. The “Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies” (SPRINTT) randomized controlled trial: Case finding, screening, and characteristics of eligible participants. Exp Gerontol. 2018;113:48–57.

    Article  PubMed  Google Scholar 

  25. Ooi PH, Gilmour SM, Yap J, Mager DR. Effects of branched chain amino acid supplementation on patient care outcomes in adults and children with liver cirrhosis: a systematic review. Clin Nutr ESPEN. 2018;28:41–51.

    Article  CAS  PubMed  Google Scholar 

  26. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol. 2019;70(1):172–93.

    Article  Google Scholar 

  27. Tsien CD, McCullough AJ, Dasarathy S. Late evening snack: exploiting a period of anabolic opportunity in cirrhosis. J Gastroenterol Hepatol. 2012;27:430–41.

    Article  CAS  PubMed  Google Scholar 

  28. Cabre E, Gonzalez-Huix F, Abad-Lacruz A, Esteve M, Acero D, Fernandez-Bañares F, et al. Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. A randomized controlled trial. Gastroenterology. 1990;98(3):715–20. PMID: 2105256.

    Article  CAS  PubMed  Google Scholar 

  29. Fan ST, Lo CM, Lai EC, Chu KM, Liu CL, Wong J. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med. 1994;331(23):1547–52.

    Article  CAS  PubMed  Google Scholar 

  30. Le Cornu KA, McKiernan FJ, Kapadia SA, Neuberger JM. A prospective randomized study of preoperative nutritional supplementation in patients awaiting elective orthotopic liver transplantation. Transplantation. 2000;69(7):1364–9.

    Article  PubMed  Google Scholar 

  31. Plank LD, Mathur S, Gane EJ, Peng SL, Gillanders LK, McIlroy K, Chavez CP, Calder PC, McCall JL. Perioperative immunonutrition in patients undergoing liver transplantation: a randomized double-blind trial. Hepatology. 2015;61(2):639–47.

    Article  CAS  PubMed  Google Scholar 

  32. Fialla AD, Israelsen M, Hamberg O, Krag A, Gluud LL. Nutritional therapy in cirrhosis or alcoholic hepatitis: a systematic review and meta-analysis. Liver Int. 2015;35(9):2072–8.

    Article  PubMed  Google Scholar 

  33. Koretz RL, Avenell A, Lipman TO. Nutritional support for liver disease. Cochrane Database Syst Rev. 2012;5:CD008344.

    Google Scholar 

  34. Antar R, Wong P, Ghali P. A meta-analysis of nutritional supplementation for management of hospitalized alcoholic hepatitis. Can J Gastroenterol. 2012;26(7):463–7.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Koretz RL, Avenell A, Lipman TO. Nutritional support for liver disease. Cochrane Database Syst Rev. 2012;5:CD008344.

    Google Scholar 

  36. Plauth M, Cabré E, Campillo B, Kondrup J, Marchesini G, Schütz T, Shenkin A, Wendon J, ESPEN. ESPEN guidelines on parenteral nutrition: hepatology. Clin Nutr. 2009;28:436–44. https://doi.org/10.1016/j.clnu.2009.04.019. Epub 2009 Jun 11.

    Article  PubMed  Google Scholar 

  37. Bianchi GP, Marchesini G, Fabbri A, Rondelli A, Bugianesi E, Zoli M, Pisi E. Vegetable versus animal protein diet in cirrhotic patients with chronic encephalopathy. A randomized cross-over comparison. J Intern Med. 1993;233(5):385–92.

    Article  CAS  PubMed  Google Scholar 

  38. Maharshi S, Sharma BC, Sachdeva S, Srivastava S, Sharma P. Efficacy of nutritional therapy for patients with cirrhosis and minimal hepatic encephalopathy in a randomized trial. Clin Gastroenterol Hepatol. 2016;14(3):454–460.e3.

    Article  PubMed  Google Scholar 

  39. Gheorghe L, Iacob R, Vădan R, Iacob S, Gheorghe C. Improvement of hepatic encephalopathy using a modified high-calorie high-protein diet. Rom J Gastroenterol. 2005;14(3):231–8.

    PubMed  Google Scholar 

  40. Córdoba J, López-Hellín J, Planas M, Sabín P, Sanpedro F, Castro F, Esteban R, Guardia J. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. Jm Hepatol. 2004;41(1):38–43.

    Article  CAS  Google Scholar 

  41. Kondrup J, Müller MJ. Energy and protein requirements of patients with chronic liver disease. J Hepatol. 1997;27(1):239–47. Review. PMID: 9252101.

    Google Scholar 

  42. Gluud LL, Dam G, Les I, Marchesini G, Borre M, Aagaard NK, Vilstrup H. Branched-chain amino acids for people with hepatic encephalopathy. Cochrane Database Syst Rev. 2017;5:CD001939.

    PubMed  Google Scholar 

  43. Horst D, Grace ND, Conn HO, Schiff E, Schenker S, Viteri A, Law D, Atterbury CE. Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial. Hepatology. 1984;4(2):279–87.

    Article  CAS  PubMed  Google Scholar 

  44. Christie ML, Sack DM, Pomposelli J, Horst D. Enriched branched-chain amino acid formula versus a casein-based supplement in the treatment of cirrhosis. JPEN J Parenter Enteral Nutr. 1985;9(6):671–8.

    Article  CAS  PubMed  Google Scholar 

  45. Marchesini G, Bianchi G, Merli M, Amodio P, Panella C, Loguercio C, Rossi Fanelli F, Abbiati R, Italian BCAA Study Group. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology. 2003;124(7):1792–801.

    Article  CAS  PubMed  Google Scholar 

  46. Les I, Doval E, García-Martínez R, Planas M, Cárdenas G, Gómez P, Flavià M, Jacas C, Mínguez B, Vergara M, Soriano G, Vila C, Esteban R, Córdoba J. Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study. Am J Gastroenterol. 2011;106(6):1081–8.

    Article  CAS  PubMed  Google Scholar 

  47. Ruiz-Margáin A, Macías-Rodríguez RU, Ríos-Torres SL, Román-Calleja BM, Méndez-Guerrero O, Rodríguez-Córdova P, Torre A. Effect of a high-protein, high-fiber diet plus supplementation with branched-chain amino acids on the nutritional status of patients with cirrhosis. Rev Gastroenterol Mex. 2018;83(1):9–15.

    Google Scholar 

  48. Kitajima Y, Takahashi H, Akiyama T, Murayama K, Iwane S, Kuwashiro T, Tanaka K, et al. Supplementation with branched-chain amino acids ameliorates hypoalbuminemia, prevents sarcopenia, and reduces fat accumulation in the skeletal muscles of patients with liver cirrhosis. J Gastroenterol. 2017;24.

    Google Scholar 

  49. Hiraoka A, Michitaka K, Kiguchi D, Izumoto H, Ueki H, Kaneto M, et al. Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2017;29(12):1416–23.

    Article  CAS  PubMed  Google Scholar 

  50. Uojima H, Sakurai S, Hidaka H, Kinbara T, Sung JH, Ichita C, Tokoro S, Masuda S, Sasaki A, Koizumi K, Egashira H, Kako M, Kobayashi S. Effect of branched-chain amino acid supplements on muscle strength and muscle mass in patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2017;29(12):1402–7.

    Article  CAS  PubMed  Google Scholar 

  51. Carroll B, Korolchuk VI, Sarkar S. Amino acids and autophagy: cross-talk and co-operation to control cellular homeostasis. Amino Acids. 2015;47:2065–88. https://doi.org/10.1007/s00726-014-1775-2.

    Article  CAS  PubMed  Google Scholar 

  52. Tsien C, Davuluri G, Singh D, Allawy A, Ten Have GA, Thapaliya S, et al. Metabolic and molecular responses to leucine-enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis. Hepatology. 2015;61(6):2018–29.

    Article  CAS  PubMed  Google Scholar 

  53. Román E, Torrades MT, Nadal MJ, Cárdenas G, Nieto JC, Vidal S, Bascuñana H, Juárez C, Guarner C, Córdoba J, Soriano G. Randomized pilot study: effects of an exercise programme and leucine supplementation in patients with cirrhosis. Dig Dis Sci. 2014;59(8):1966–75.

    Article  CAS  PubMed  Google Scholar 

  54. Aversa Z, Bonetto A, Costelli P, Minero VG, Penna F, Baccino FM, Lucia S, Rossi Fanelli F, Muscaritoli M. β-Hydroxy-β-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia. Int J Oncol. 2011;38(3):713–20.

    CAS  PubMed  Google Scholar 

  55. Kornasio R, Riederer I, Butler-Browne G, Mouly V, Uni Z, Halevy O. Beta-hydroxy-betamethylbutyrate (HMB) stimulates myogenic cell proliferation, differentiation, and survival via the MAPK/ERK and PI3K/Akt pathways. Biochim Biophys Acta. 2009;1793(5):755–63.

    Article  CAS  PubMed  Google Scholar 

  56. Smith HJ, Mukerji P, Tisdale MJ. Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss. Cancer Res. 2005;65(1):277–83.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Manuela Merli .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Merli, M., Lattanzi, B., D’Ambrosio, D., Fabrini, N., Liguori, A. (2020). Nutritional Therapy in the Management of Physical Frailty and Sarcopenia. In: Tandon, P., Montano-Loza, A. (eds) Frailty and Sarcopenia in Cirrhosis. Springer, Cham. https://doi.org/10.1007/978-3-030-26226-6_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-26226-6_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-26225-9

  • Online ISBN: 978-3-030-26226-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics